<DOC>
	<DOC>NCT01604018</DOC>
	<brief_summary>Cat allergy is an increasingly prevalent condition affecting 10-15% of patients with allergic rhinoconjunctivitis and/or asthma. The purpose of this optional observational follow-on study is to further evaluate rhinoconjunctivitis symptoms on exposure to cat dander in the EEC among subjects who completed all dosing visits in study CP005 and all visits in study CP005A approximately two years after the start of treatment.</brief_summary>
	<brief_title>An Optional Two Year Follow Up Study to Study CP005A</brief_title>
	<detailed_description>Subjects who completed all visits in studies CP005 and CP005A will be invited to attend the Screening Visit for CP005B. Subjects will attend for 4 visits to the EEC on successive days. Following the last EEC visit is a follow-up visit which will be performed 3-10 days later.</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<criteria>Previously randomised into study CP005 and completed all visits in the followon study CP005A "Partly controlled" and "uncontrolled" asthma History of anaphylaxis to cat allergen Subjects with an FEV1 &lt; 70% of predicted Subjects who cannot tolerate baseline challenge in the EEC Treatment with betablockers, alphaadrenoceptor blockers, tranquilizers, or psychoactive drugs Symptoms of a clinically relevant illness, in the Investigator's opinion, within 6 weeks prior to Screening Visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Cat Allergy</keyword>
	<keyword>Rhinoconjunctivitis</keyword>
</DOC>